Engerix-B 20, Injektionssuspension

7680005340047 CH-534 Injektionssuspension
Engerix-B 20, Injektionssuspension
Engerix-B 20, Injektionssuspension
Engerix-B 20, Injektionssuspension
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 UG Substance Wirkstoff (Principe actif)
(N/A)
0.5 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.52 MG Substance HBESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
534
Drug name
Engerix-B 20, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BC01
Authorization status
Z
Dispensing category
B
First authorization
03/12/1986
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Hepatitis B, ab dem vollendeten 18. Lebensjahr

Package details

Description (FR)
ENGERIX B 20 susp inj adult (n ser pré) 10 x 1 ml
Description (DE)
ENGERIX B 20 Inj Susp Erw (n Fertspr) 10 x 1 ml
Market launch
03/12/1986
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (3)

ENGERIX B 20 susp inj adult ser pré 1 ml
None None
GTIN: 7680005340016
View
ENGERIX B 20 susp inj adult 10 ser pré 1 ml
None None
GTIN: 7680005340023
Not in V1
ENGERIX B 20 susp inj adult (n ser pré) 1 ml
1 FESP
GTIN: 7680005340030
View